Effectiveness and safety of Compound Danshen injection as treatment for pregnancy-induced hypertension: A metaanalysis

  • Xiuqin Wang
  • Donghua Guo
  • Ailong Yang
  • Yu Wang
  • Ruifang Wang
  • Jiale Li
Keywords: Pregnancy-induced hypertension (PIH), Compound Danshen injection, Meta-analysis

Abstract

Purpose: To systematically evaluate the effectiveness and safety of Compound Danshen injection in patients with pregnancy-induced hypertension (PIH).
Methods: PubMed, Embase, Cochrane Library, Chinese biomedical literature database (CBM), VIP (xiAn), China National Knowledge Infrastructure (CNKI) and Wan Fang databases were searched up to March 20, 2018, for all randomized controlled trials (RCTs) on the use of Compound Danshen injection in patients with PIH. Data were extracted from included studies after assessing the quality of literature. Revman 5.3 software was used for statistical analysis.
Results: A total of 18 RCTs involving 1735 patients were included. The results of meta-analysis indicated that the study group was superior to the control group in clinical effectiveness (RR = 1.15, 95 % CI: 1.02 - 1.30); intrauterine fetal distress (RR = 0.26, 95 % CI: 0.09 - 0.70); cesarean section (RR = 0.72, 95 % CI: 0.58 - 0.90), and neonatal asphyxia (RR = 0.23, 95 % CI: 0.11 - 0.48). There were no statistical differences in fetal heart rate abnormalities (RR = 0.58, 95 %, CI: 0.33 - 1.02, p > 0.05) and postpartum hemorrhage (RR = 0.86, 95 % CI: 0.53 - 1.42) between the two groups.
Conclusion: Treatment of PIH with Compound Danshen injection (alone or in combination) is superior to the use of conventional western medical treatment in safety and effectiveness. However, higher quality clinical studies are needed to confirm these results because most trials included in this study were of low quality.

Keywords: Pregnancy-induced hypertension (PIH), Compound Danshen injection, Meta-analysis

Section
Articles

Journal Identifiers


eISSN: 1596-9827
print ISSN: 1596-5996